Literature DB >> 13819076

The use of DFP32 as a red cell tag with and without simultaneous tagging with chromium 51 in certain animals in the presence or absence of random destruction.

G S EADIE, W W SMITH, I W BROWN.   

Abstract

DFP(32), used to label erythrocytes in vitro, combines with cell constituents in two stages, the first almost immediate and involving tributyrinase inactivation, the second slower (more than 40 minutes) involving cholinesterase inactivation. Raising the DFP concentration increases the amount irreversibly bound, but increases even more the immediate post-transfusion elution, and DFP is unsuited for investigating erythrocyte viability of stored samples. In vivo tagging by intramuscular injection is satisfactory and normal survival curves are linear since the sample tagged has normal age distribution of cells in absence of random destruction. Here DFP(32) curves are easier to interpret than Cr(51) curves. In sheep, chromium elution occurs at two different rates producing a rapid initial drop followed by a slower one of about 3 per cent daily. Random destruction alters cell age distribution. New equations are derived for cases in which this is constant both with and without chromium elution; they were applied satisfactorily to dog and sheep blood. Analysis of such curves is difficult; approximate values for random destruction rates can be obtained though not potential life spans. Chromium curves can be analyzed only with the help of DFP(32) or similar curves, and yield little additional information. DFP(32) and chromium can be used simultaneously to provide controls.

Entities:  

Keywords:  CHROMIUM/radioactive; ERYTHROCYTES; ISOFLUROPHATE

Mesh:

Substances:

Year:  1960        PMID: 13819076      PMCID: PMC2195026          DOI: 10.1085/jgp.43.4.825

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  8 in total

1.  Phosphopeptides from acid-hydrolyzed P32-labeled diisopropylphosphoryl chymotrypsin.

Authors:  N K SCHAFFER; L SIMET; S HARSHMAN; R R ENGLE; R W DRISKO
Journal:  J Biol Chem       Date:  1957-03       Impact factor: 5.157

2.  The relationship between natural and immune haemolysins and incompatibility of 51Cr labelled red cells in the sheep.

Authors:  A N DRURY; E M TUCKER
Journal:  Immunology       Date:  1958-07       Impact factor: 7.397

3.  Haemoglobin and potassium blood types in some non-British breeds of sheep and in certain rare British breeds.

Authors:  J V EVANS; H HARRIS; F L WARREN
Journal:  Nature       Date:  1958-08-02       Impact factor: 49.962

4.  The use of diisopropylfluorophosphate 32 for the determination of in-vivo red cell survival and plasma cholinesterase turnover rates.

Authors:  J R BOVE; F G EBAUGH
Journal:  J Lab Clin Med       Date:  1958-06

5.  The fate of P32 labelled diisopropylfluorophosphonate in the human body and its use as a labelling agent in the study of the turnover of blood plasma and red cells.

Authors:  J A COHEN; M G WARRINGA
Journal:  J Clin Invest       Date:  1954-03       Impact factor: 14.808

6.  THE OSMOTIC RESISTANCE (FRAGILITY) OF HUMAN RED CELLS.

Authors:  A K Parpart; P B Lorenz; E R Parpart; J R Gregg; A M Chase
Journal:  J Clin Invest       Date:  1947-07       Impact factor: 14.808

7.  Studies with inagglutinable erythrocyte counts. III. Kinetics of erythrocyte destruction in human beings.

Authors:  R F SHEETS; C D JANNEY; H E HAMILTON; E L DeGOWIN
Journal:  J Clin Invest       Date:  1951-11       Impact factor: 14.808

8.  An analytical study of in vivo survival of limited populations of animal red blood cells tagged with radio-iron.

Authors:  I W BROWN; G S EADIE
Journal:  J Gen Physiol       Date:  1953-01       Impact factor: 4.086

  8 in total
  3 in total

1.  Erythrocyte survival in normal mice and in mice with autoimmune haemolytic anaemia.

Authors:  E S Lindsey; G W Donaldson; M F Woodruff
Journal:  Clin Exp Immunol       Date:  1966-01       Impact factor: 4.330

2.  The survival time of DF 32 P-labelled erythrocytes in adult male mink.

Authors:  S M Fletch; G A Robinson; L H Karstad
Journal:  Can J Comp Med       Date:  1972-01

3.  Increased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanate.

Authors:  P N Gillette; J M Manning; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.